These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 33732706)

  • 1. Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment.
    Wu P; Gao W; Su M; Nice EC; Zhang W; Lin J; Xie N
    Front Cell Dev Biol; 2021; 9():641469. PubMed ID: 33732706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment.
    Qu Y; Dou B; Tan H; Feng Y; Wang N; Wang D
    Mol Cancer; 2019 Mar; 18(1):69. PubMed ID: 30927928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.
    Van den Bossche V; Zaryouh H; Vara-Messler M; Vignau J; Machiels JP; Wouters A; Schmitz S; Corbet C
    Drug Resist Updat; 2022 Jan; 60():100806. PubMed ID: 35121337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancers.
    Zhao D; Mo Y; Neganova ME; Aleksandrova Y; Tse E; Chubarev VN; Fan R; Sukocheva OA; Liu J
    Front Cell Dev Biol; 2023; 11():1266537. PubMed ID: 37849740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment and cancer therapy resistance.
    Sun Y
    Cancer Lett; 2016 Sep; 380(1):205-15. PubMed ID: 26272180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
    Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
    Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.
    Fakhri S; Moradi SZ; Faraji F; Farhadi T; Hesami O; Iranpanah A; Webber K; Bishayee A
    Cancer Metastasis Rev; 2023 Sep; 42(3):959-1020. PubMed ID: 37505336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of cancer metabolism on therapy resistance - Clinical implications.
    Gonçalves AC; Richiardone E; Jorge J; Polónia B; Xavier CPR; Salaroglio IC; Riganti C; Vasconcelos MH; Corbet C; Sarmento-Ribeiro AB
    Drug Resist Updat; 2021 Dec; 59():100797. PubMed ID: 34955385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies.
    Liu H; Zhao H; Sun Y
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):769-781. PubMed ID: 34799201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects.
    Peters S; Paz-Ares L; Herbst RS; Reck M
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35858709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications.
    Wu P; Han J; Gong Y; Liu C; Yu H; Xie N
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intimate communications within the tumor microenvironment: stromal factors function as an orchestra.
    Cheng B; Yu Q; Wang W
    J Biomed Sci; 2023 Jan; 30(1):1. PubMed ID: 36600243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles overcome adaptive immune resistance and enhance immunotherapy
    Zhang X; Wang X; Hou L; Xu Z; Liu Y; Wang X
    Front Pharmacol; 2023; 14():1130937. PubMed ID: 37033636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy.
    Heidegger I; Pircher A; Pichler R
    Front Oncol; 2019; 9():490. PubMed ID: 31259150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy.
    Han ZJ; Li YB; Yang LX; Cheng HJ; Liu X; Chen H
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy improves disease prognosis by affecting the tumor microenvironment: A bibliometric study.
    Wu X; Deng Z; Zhao Q
    Front Immunol; 2022; 13():967076. PubMed ID: 36275770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.